Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -36.62%3.07T | 40.42%4.85T | 31.03%3.46T | 22.20%2.64T | 20.51%2.16T | -16.93%1.79T | 49.84%2.16T | 1.44T | -55.87%914.81B | 32.48%2.07T |
| Net interest income | -39.53%1.11T | 43.57%1.83T | 46.45%1.28T | -5.41%870.91B | -15.71%920.67B | -7.86%1.09T | 9.95%1.19T | --1.08T | 3.58%1.11T | 30.25%1.07T |
| -Total interest income | 18.94%2.39T | 35.99%2.01T | 30.49%1.48T | -0.12%1.13T | -11.47%1.13T | -6.67%1.28T | 8.59%1.37T | --1.26T | 23.68%1.33T | 28.62%1.08T |
| -Total interest expense | 624.05%1.28T | -12.06%176.95B | -22.83%201.23B | 22.81%260.77B | 13.18%212.33B | 0.91%187.59B | 0.63%185.9B | --184.74B | 4,045.25%222.28B | -63.28%5.36B |
| Non interest income | -34.86%1.97T | 38.57%3.02T | 23.43%2.18T | 42.75%1.77T | 77.19%1.24T | -28.02%698.15B | 169.19%969.97B | --360.33B | -119.69%-196.88B | 34.96%999.65B |
| -Fees and commissions | -1.82%-47.41B | -30.21%-46.57B | 12.11%-35.76B | -0.63%-40.69B | -3.03%-40.44B | 8.45%-39.25B | -551.83%-42.87B | --9.49B | -479.27%-41.38B | 0.75%10.91B |
| -Including:Fees and commission income | 0.03%9.88B | -31.35%9.88B | 63.13%14.39B | 1.07%8.82B | -2.96%8.73B | -2.55%8.99B | -3.79%9.23B | --9.59B | -4.55%10.41B | 0.75%10.91B |
| -Including:Fees and commission expense | 1.50%57.29B | 12.55%56.45B | 1.29%50.15B | 0.70%49.51B | 1.91%49.16B | -7.40%48.24B | 49,308.54%52.1B | --105.44M | --51.79B | ---- |
| -Dividend income | 42.25%1.34B | 9.92%944.35M | -39.09%859.14M | --1.41B | ---- | 0.61%631.37M | -21.55%627.54M | --799.9M | 14.89%669.71M | -27.29%582.9M |
| -Gain loss on sale of securities | 9.47%1.81T | 11.59%1.65T | 26.51%1.48T | 16.30%1.17T | 23.19%1.01T | 14.55%817.76B | 30.17%713.89B | --548.42B | 42.86%166.78B | 35.00%116.75B |
| -Total other operating income | -85.64%202.82B | 92.80%1.41T | 15.58%732.33B | 134.57%633.59B | 433.48%270.1B | -127.15%-81B | 250.38%298.32B | ---198.38B | -137.06%-322.95B | 35.61%871.41B |
| Credit losses provision | ||||||||||
| Operating expense | -57.70%755.16B | 68.41%1.79T | 7.93%1.06T | 39.53%982.2B | 63.97%703.95B | -60.35%429.31B | 97.47%1.08T | 548.32B | 10.86%398.16B | 26.39%359.16B |
| Staff costs | -0.82%52.3B | 2.61%52.73B | 0.27%51.39B | 0.07%51.26B | -1.80%51.22B | 1.05%52.16B | -0.32%51.62B | --51.78B | 1.23%50.75B | 6.19%50.13B |
| Selling and administrative expenses | 2.90%78.41B | -1.30%76.2B | 7.33%77.2B | 4.06%71.93B | -1.25%69.12B | -6.90%70B | 3.36%75.19B | --72.75B | -45.35%72.36B | 3.36%132.41B |
| -Selling and marketing expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -6.36%107.44M |
| -General and administrative expense | 2.90%78.41B | -1.30%76.2B | 7.33%77.2B | 4.06%71.93B | -1.25%69.12B | -6.90%70B | 3.36%75.19B | --72.75B | -45.31%72.36B | 3.37%132.31B |
| Depreciation and amortization | -2.83%17.54B | 6.89%18.06B | 13.60%16.89B | -3.85%14.87B | -0.04%15.46B | 0.90%15.47B | 4.31%15.33B | --14.7B | -0.30%15.03B | -3.43%15.08B |
| -Depreciation | -2.83%17.54B | 6.89%18.06B | 13.60%16.89B | -3.85%14.87B | -0.04%15.46B | 0.90%15.47B | 4.31%15.33B | --14.7B | -0.30%15.03B | -3.43%15.08B |
| Other operating expenses | -62.95%606.9B | 79.13%1.64T | 8.34%914.57B | 48.58%844.14B | 94.78%568.14B | -68.99%291.68B | 129.94%940.65B | --409.09B | 60.97%260.02B | 73.27%161.54B |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -53.03%1.83B | -76.70%3.89B | 71.68%16.71B | 1,329.47%9.73B | -113.64%-791.48M | 164.81%5.8B | 1,203.99%2.19B | -198.54M | 100.14%521.43M | -21.21%-362.3B |
| Less:Other special charges | 53.03%-1.83B | 76.70%-3.89B | -71.68%-16.71B | -1,329.47%-9.73B | 113.64%791.48M | -164.81%-5.8B | -1,203.99%-2.19B | --198.54M | -100.14%-521.43M | 21.21%362.3B |
| Income before tax | -24.39%2.32T | 27.30%3.07T | 44.91%2.41T | 14.55%1.66T | 6.30%1.45T | 27.18%1.37T | 20.77%1.07T | 889.96B | -61.73%517.17B | 37.67%1.35T |
| Income tax | -92.72%57.03B | 141.52%782.89B | -4.58%324.14B | 45.27%339.7B | 226.45%233.84B | -85.32%71.63B | 289.76%487.84B | 125.16B | -69.02%106.09B | 33.03%342.41B |
| Net income | -1.00%2.26T | 9.56%2.29T | 57.60%2.09T | 8.65%1.32T | -5.88%1.22T | 120.68%1.3T | -23.25%586.96B | 764.8B | -59.26%411.08B | 39.32%1.01T |
| Net income continuous operations | -1.00%2.26T | 9.56%2.29T | 57.60%2.09T | 8.65%1.32T | -5.88%1.22T | 120.68%1.3T | -23.25%586.96B | --764.8B | -59.26%411.08B | 39.32%1.01T |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -1.00%2.26T | 9.56%2.29T | 57.60%2.09T | 8.65%1.32T | -5.88%1.22T | 120.68%1.3T | -23.25%586.96B | 764.8B | -59.26%411.08B | 39.32%1.01T |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -1.00%2.26T | 9.56%2.29T | 57.60%2.09T | 8.65%1.32T | -5.88%1.22T | 120.68%1.3T | -23.25%586.96B | 764.8B | -59.26%411.08B | 39.32%1.01T |
| Gross dividend payment | ||||||||||
| Basic earnings per share | ||||||||||
| Diluted earnings per share | ||||||||||
| Dividend per share | ||||||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |